[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352447-105":59,"doc-detail-352447-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","standardizing-clinical-trials-in-near-infrared-fluorescence-imaging-a-workflow-and-regulatory-framework-proposal-perspective","Standardizing clinical trials in near-infrared fluorescence imaging: a workflow and regulatory framework proposal - Perspective","","Near-infrared fluorescence imaging (NIR) is an emerging modality for real-time, precise visualization of (pre)cancerous tissue during surgical and endoscopic procedures. Growing adoption is limited by the absence of standardized clinical trial protocols, which reduces comparability and delays broader clinical use. The manuscript analyzes drivers of fluorescence signal variability, separates them into non-adaptable and adaptable factors, and proposes a workflow with guidelines to standardize trial protocols, support reproducibility, and facilitate regulatory approval.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/standardizing-clinical-trials-in-near-infrared-fluorescence-imaging-a-workflow-and-regulatory-framework-proposal-perspective/352447/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/standardizing-clinical-trials-in-near-infrared-fluorescence-imaging-a-workflow-and-regulatory-framework-proposal-perspective/352447.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are standardized clinical trial protocols needed for NIR fluorescence imaging?","Question",{"text":112,"@type":113},"Without standard protocols, trial results are less comparable, which slows validation and broader clinical adoption of NIR fluorescence imaging.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are the main factors affecting fluorescence signal variability?",{"text":117,"@type":113},"The manuscript identifies key factors and categorizes them into non-adaptable and adaptable sources of variability.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the proposed work provide beyond new clinical datasets?",{"text":121,"@type":113},"As a Perspective, it outlines a standardization framework, including a comprehensive workflow and guidelines, to advance NIR imaging toward routine clinical use and improved patient outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352447,1790871213,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","npj | imaging Perspective  \n\n| \u003Cbr>[https://doi.org/10.1038/s44303-026-00139-w](https://doi.org/10.1038/s44303-026-00139-w) |  |\n| --- | --- |\n| Standardizing clinical trials in nearinfrared ﬂ uorescence imaging: a workﬂowand regulatory framework proposal\u003Cbr> Check for updates |  |\n| Lisanne K. A. Neijenhuis1,2,3, Tom H. Dijkhuis2, Michael J. Mandella1, Samuel J. S. Rubin1, Jacobus Burggraaf 2,3, Alexander L. Vahrmeijer 2 & Stephan Rogalla1  |  |\n| Near-infrared ﬂuorescence imaging (NIR) is an emerging imaging modality that enhances the realtime, precise visualization of (pre)cancerous tissue during surgical and endoscopic procedures. Despite its growing adoption, the lack of standardized protocols in clinical trials hinders the comparability of results and broader clinical adaptation. This manuscript identiﬁes key factors inﬂuencing ﬂuorescence signal variability, categorizing them into non-adaptable and adaptable. We propose a comprehensive workﬂow and guidelines to standardize clinical trial protocols, ensuring reproducibility and facilitating regulatory approval. As a Perspective, we outline a standardization framework—rather than new clinical datasets—to advance NIR imaging toward routine clinical use and improved patient outcomes. |  |\n| Near-infrared ﬂuorescence imaging\u003Cbr>Each year, approximately 19.3 million people are diagnosed with cancer globally, with around 10 million cancer-related deaths annually1. Early and accurate detection is crucial for improving patient outcomes2,3. However, multiple challenges in both the diagnosis and treatment of (pre)malignant conditions remain. White-light endoscopy is commonly used for screening and surveillance of gastrointestinal (GI) cancers, but it has a high rate of missed lesions, especially in high-risk patients with conditions such as Barrett’s esophagus, ﬂat polyps, inﬂammatory bowel disease, and Lynch syndrome4–6. Differentiating between cancers and ﬁbrosis during posttreatment surveillance endoscopy is equally difﬁcult due to impaired mucosa7.\u003Cbr>Surgical resection remains the cornerstone in the curative-intended treatment of non-metastasized solid tumors, where complete resection is essential since incomplete resection of the tumor is associated with tumor relapse and signiﬁcantly worsened survival rates8–10. Intraoperative identiﬁcation of the tumor can be challenging, especially with minimally invasive surgical procedures that lack tactile feedback. NIR ﬂuorescence imaging isan emerging imaging technique that helps clinicians identify tumors during screening and surveillance and assists surgeons in localizing the tumor and preventing tumor-positive resection margins intraoperatively2, 11–17.\u003Cbr>This imaging technique utilizes NIR light (700–900 nm), which minimizes autoﬂuorescence and optimizes contrast between ﬂuorescent signals in tumor and healthy tissue, allowing for deeper tissue penetration (up to 10 mm) compared to visible white-light without interfering with the | normal endoscopic or surgical ﬁeld, as it is invisible to the human eye18, 19. Three key components are essential: a targeting ﬂuorescent agent, a light source, and a camera (Fig. 1). The light source emits photons that are absorbed by the ﬂuorophore. The ﬂuorophore then enters an excited state and subsequently emits photons with a longer wavelength as it returns to its ground state. These photons are captured by the camera and displayed in real-time12,20. In the oncology setting—both during endoscopy and surgery—a ﬂuorescent tumor-targeting agent should be used. This ﬂuorescent agent binds to the tumor and, when illuminated by a near-infrared (NIR) light source, emits photons that highlight the tumor tissue where it has bound. In this way, both primary tumors and metastases, including occult lesions, can potentially be visualized during endoscopy or surgery13, 18, 19.\u003Cbr>Not only in theﬁeld ofoncology, there are visualization challenges, but there are also similar visualization challenges driving the","cbCaiuSrNx8TuIeG","https://ap.wps.com/l/cbCaiuSrNx8TuIeG","pdf",1388105,"English","# Clinical need and rationale\n## Imaging challenges in diagnosis and treatment\n## NIR fluorescence imaging basics\n# Proposed standardization approach\n## Sources of signal variability\n## Workflow and protocol guidelines\n## Regulatory and reproducibility implications","[{\"question\":\"Why are standardized clinical trial protocols needed for NIR fluorescence imaging?\",\"answer\":\"Without standard protocols, trial results are less comparable, which slows validation and broader clinical adoption of NIR fluorescence imaging.\"},{\"question\":\"What are the main factors affecting fluorescence signal variability?\",\"answer\":\"The manuscript identifies key factors and categorizes them into non-adaptable and adaptable sources of variability.\"},{\"question\":\"What does the proposed work provide beyond new clinical datasets?\",\"answer\":\"As a Perspective, it outlines a standardization framework, including a comprehensive workflow and guidelines, to advance NIR imaging toward routine clinical use and improved patient outcomes.\"}]","Standardizing clinical trials in near-infrared fluorescence imaging: a workflow and regulatory framework proposal - Perspective | PDF",1790099671,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/baba50ead939f156c479f4d0620f2faf.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/339c98040587b59a9810588a84bc1e7f.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0472c1d8f851602f7ebfd4b2a9aadae0.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b345a228bad9be6f557bb02843b83faf.webp",980,1301]